British Columbia Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Sell
280,572
-80,611
-22% -$4.7M 0.1% 155
2025
Q4
$19.5M Buy
361,183
+68,388
+23% +$3.29M 0.1% 181
2025
Q3
$13.2M Sell
292,795
-27,384
-9% -$1.28M 0.08% 205
2025
Q2
$14.8M Sell
320,179
-67,711
-17% -$3.32M 0.09% 186
2025
Q1
$23.7M Sell
387,890
-338
-0.1% -$19.7K 0.15% 142
2024
Q4
$22M Buy
388,228
+49,996
+15% +$2.79M 0.13% 153
2024
Q3
$17.5M Sell
338,232
-49,989
-13% -$2.35M 0.11% 161
2024
Q2
$16.1M Buy
388,221
+144,467
+59% +$6.46M 0.1% 171
2024
Q1
$13.2M Buy
243,754
+3,282
+1% +$167K 0.09% 161
2023
Q4
$12.3M Buy
240,472
+49,446
+26% +$2.6M 0.1% 156
2023
Q3
$11.1M Buy
191,026
+980
+0.5% +$60K 0.11% 138
2023
Q2
$12.2M Sell
190,046
-40
-0% -$2.68K 0.11% 136
2023
Q1
$13.2M Buy
190,086
+600
+0.3% +$42.3K 0.14% 118
2022
Q4
$13.6M Sell
189,486
-21,493
-10% -$1.62M 0.15% 123
2022
Q3
$15M Sell
210,979
-42,256
-17% -$3.07M 0.17% 104
2022
Q2
$19.5M Sell
253,235
-89,852
-26% -$6.84M 0.19% 101
2022
Q1
$25.1M Sell
343,087
-47,581
-12% -$3.19M 0.16% 108
2021
Q4
$24.4M Sell
390,668
-22,440
-5% -$1.32M 0.14% 127
2021
Q3
$24.4M Sell
413,108
-1,325
-0.3% -$87.3K 0.14% 116
2021
Q2
$27.7M Buy
414,433
+43,240
+12% +$2.82M 0.17% 111
2021
Q1
$23.4M Sell
371,193
-10,077
-3% -$627K 0.17% 109
2020
Q4
$23.6M Sell
381,270
-11,510
-3% -$708K 0.17% 112
2020
Q3
$23.7M Buy
392,780
+30,730
+8% +$1.85M 0.19% 102
2020
Q2
$21.3M Buy
362,050
+105,718
+41% +$6.32M 0.21% 101
2020
Q1
$14.3M Sell
256,332
-296,911
-54% -$18.1M 0.24% 82
2019
Q4
$35.5M Sell
553,243
-26,540
-5% -$1.52M 0.26% 90
2019
Q3
$29.4M Sell
579,783
-79,814
-12% -$3.75M 0.28% 88
2019
Q2
$29.9M Buy
659,597
+13,811
+2% +$643K 0.26% 92
2019
Q1
$30.8M Sell
645,786
-38,445
-6% -$1.92M 0.27% 94
2018
Q4
$35.6M Buy
684,231
+108,847
+19% +$5.85M 0.32% 78
2018
Q3
$35.7M Sell
575,384
-189,839
-25% -$11.3M 0.38% 59
2018
Q2
$42.3M Sell
765,223
-142,883
-16% -$7.72M 0.37% 55
2018
Q1
$57.4M Sell
908,106
-61,202
-6% -$3.94M 0.44% 49
2017
Q4
$59.4M Buy
969,308
+20,598
+2% +$1.29M 0.42% 51
2017
Q3
$60.5M Sell
948,710
-86,736
-8% -$5.06M 0.47% 44
2017
Q2
$57.7M Sell
1,035,446
-24,186
-2% -$1.32M 0.46% 42
2017
Q1
$57.6M Buy
1,059,632
+59,193
+6% +$3.25M 0.46% 44
2016
Q4
$58.5M Buy
1,000,439
+102,307
+11% +$5.59M 0.51% 44
2016
Q3
$48.4M Sell
898,132
-127,762
-12% -$8.21M 0.49% 46
2016
Q2
$75.5M Buy
1,025,894
+19,290
+2% +$1.36M 0.66% 33
2016
Q1
$64.3M Buy
1,006,604
+52,981
+6% +$3.34M 0.6% 39
2015
Q4
$65.6M Sell
953,623
-2,309
-0.2% -$153K 0.63% 37
2015
Q3
$56.6M Sell
955,932
-9,940
-1% -$631K 0.58% 38
2015
Q2
$64.3M Sell
965,872
-14,455
-1% -$953K 0.61% 35
2015
Q1
$63.2M Sell
980,327
-261,714
-21% -$16.4M 0.57% 40
2014
Q4
$73.3M Sell
1,242,041
-7,505
-0.6% -$423K 0.61% 32
2014
Q3
$64M Sell
1,249,546
-51,509
-4% -$2.57M 0.54% 42
2014
Q2
$63.1M Sell
1,301,055
-4,493
-0.3% -$221K 0.51% 44
2014
Q1
$67.8M Sell
1,305,548
-77,489
-6% -$4.12M 0.57% 40
2013
Q4
$73.5M Buy
1,383,037
+126,702
+10% +$6.45M 0.58% 41
2013
Q3
$58.1M Sell
1,256,335
-247,358
-16% -$10.9M 0.49% 48
2013
Q2
$67.2M Buy
+1,503,693
New +$65.3M 0.55% 39

Other funds holding BMY

British Columbia Investment Management's BMY Position: Q1 2026 in Review

British Columbia Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, selling an estimated $4.7M and leaving 280,572 shares worth $17M. The position accounts for 0.1% of the portfolio, ranked #155.

British Columbia Investment Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $75.5M in Q2 2016. 2,522 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • British Columbia Investment Management held 280,572 shares of Bristol-Myers Squibb worth $17M as of Q1 2026.
  • British Columbia Investment Management sold 80,611 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.7M.
  • Bristol-Myers Squibb made up 0.1% of British Columbia Investment Management's portfolio in Q1 2026, its #155 holding.
  • British Columbia Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Bristol-Myers Squibb position peaked at $75.5M in Q2 2016.
  • 2,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.